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Abstract
Background: Endothelial dysfunction is thought to be a potential mechanism for the decreased
presence of coronary collaterals. The aim of the study was to investigate the association between
systemic endothelial function and the extent of coronary collaterals.
Methods:  We investigated the association between endothelial function assessed via flow
mediated dilation (FMD) of the brachial artery following reactive hyperemia and the extent of
coronary collaterals graded from 0 to 3 according to Rentrop classification in a cohort of 171
consecutive patients who had high grade coronary stenosis or occlusion on their angiograms.
Results: Mean age was 61 years and 75% were males. Of the 171 patients 88 (51%) had well
developed collaterals (grades of 2 or 3) whereas 83 (49%) had impaired collateral development
(grades of 0 or 1). Patients with poor collaterals were significantly more likely to have diabetes (p
= 0.001), but less likely to have used statins (p = 0.083). FMD measurements were not significantly
different among good and poor collateral groups (11.5 ± 5.6 vs. 10.4 ± 6.2% respectively, p = 0.214).
Nitroglycerin mediated dilation was also similar (13.4 ± 5.9 vs. 12.8 ± 6.5%, p = 0.521).
Conclusion: No significant association was found between the extent of angiographically visible
coronary collaterals and systemic endothelial function assessed by FMD of the brachial artery.
Background
Ischemic heart disease and myocardial infarction are the
major causes of mortality and morbidity in industrialized
countries. Well developed coronary collateral vessels have
protective impacts such as limiting the size of myocardial
infarction, reducing the incidence of heart failure and ven-
tricular aneurysm, fewer cardiovascular events during fol-
low-up and better survival rates [1-3]. However, there are
significant differences in the degree of collateral develop-
ment among individual patients [4]. Although clinical
presentation with stable angina pectoris, presence of dia-
betes mellitus, the extent of coronary artery stenosis, the
use of calcium channel blockers, statins, angiotensin con-
verting enzyme inhibitors, elevated levels of C-reactive
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protein, and the number and function of endothelial pro-
genitor cells were all suggested as potential determinants
of collateral development, it is still unknown why some
patients are capable of developing sufficient collateral cir-
culation while others are not [5-8].
Recent studies have demonstrated that, nitric oxide (NO)
bioavailability is critically important in collateral forma-
tion [9-11]. This led to a common perception that
endothelial dysfunction is one of the potential mecha-
nisms for the decreased presence of coronary collaterals.
To date, however, the relation between endothelial func-
tion and collateral development has not been evaluated in
clinical studies. Endothelial function can be assessed non-
invasively via flow-mediated dilation (FMD) of the bra-
chial artery using high resolution ultrasound [12,13].
The current study was undertaken to assess whether
endothelial function, measured by FMD, is associated
with the extent of angiographically visible coronary collat-




All patients who underwent coronary angiography at our
institution, and were found to have at least one major cor-
onary occlusion, or a stenosis of ≥ 95% with Thromboly-
sis In Myocardial Infarction (TIMI) grade ≤ 1 anterograde
flow were screened for eligibility. Patients with diagnosis
of acute coronary syndrome within the past 15 days, and
patients who have undergone coronary angiography using
right radial approach were excluded. Patients with a his-
tory of coronary bypass surgery were also excluded if (1)
the operation has been done within the past 30 days, and
(2) the distal aspect of the qualifying severely stenosed or
occluded artery is supplied by the patent bypass graft.
All patients gave written informed consent and local eth-
ics committee approved the study protocol.
Coronary angiography and collateral scoring
Coronary angiography was routinely performed by the
Judkins method without the use of nitroglycerin. Percent-
age diameter stenosis was measured by using computer-
ized quantitative angiography in a biplane mode (Philips
DCI, Eindhoven, Netherlands). Two experienced inter-
ventional cardiologists (A.O.O and C.T.K) who were
blinded to patient characteristics reviewed the angiograms
and graded the coronary collaterals according to Rentrop
classification [14]. In subjects with >1 collateral supplying
the distal aspect of the diseased artery, the higher collat-
eral grade was used. In subjects with >1 qualifying severely
diseased vessel, the vessel with the higher collateral grade
was chosen for analysis.
Intra- and inter-observer agreement of coronary collateral
grades were determined from a random sample of 50 cor-
onary angiograms (Kappa values were 0.935 for intra- and
0.845 for interobserver agreements; p < 0.001 for both of
them). Disagreements were resolved by an additional
joint reading. Patients were divided into two groups
according to their collateral grades. Group 1 consisted of
patients with grade 0 or grade 1 collaterals (poor collateral
group) and group 2 consisted of patients with grade 2 or
grade 3 collaterals (good collateral group).
Risk factor assessment
Information about smoking, and alcohol consumption
was collected through interview directly from the patients.
Medical records were reviewed for reports of previous
myocardial infarction, coronary artery bypass grafting,
and percutaneous coronary intervention. Body mass
index was calculated as weight (kg) divided by height
(m2). Hypertension was defined as systolic blood pressure
≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, or
use of antihypertensive medication in the previous two
weeks. Diabetes was defined as fasting blood glucose ≥
126 mg/dL, nonfasting blood glucose ≥ 200 mg/dL, or use
of antidiabetic medication in the previous two weeks.
Diagnosis of acute coronary syndrome (ACS) was made
according to the guidelines established by the American
College of Cardiology and the American Heart Associa-
tion [15]. Non-ACS patients had stable angina and/or
positive stress tests.
Left ventricular ejection fraction was calculated by con-
trast venticulography using a standard area-length for-
mula [16] (n = 65) or estimated by echocardiography
when ventriculography was not performed (n = 106). Sig-
nificant stenosis was defined as quantitatively measured
diameter stenosis of >70% in any of the major coronary
arteries.
Endothelium dependent and independent flow-mediated 
vasodilation (FMD)
Endothelium dependent and independent flow-mediated
dilation were performed by using a 13.0 MHz linear array
transducer (Vivid 7, Wipro GE Healtcare, GE Medical Sys-
tems Inc, Chicago, U.S.A) on the day after coronary angi-
ography. After 12 h fasting (including caffeine, nicotine
and alcohol), vascular measurements were performed in a
quiet, temperature controlled (22–24°C) room early in
the morning (8 am-10 am). Vasoactive medications were
not stopped before FMD, but the morning doses were
skipped on the examination day of FMD. After 15 min
resting period in the supine position, the transducer was
placed 4–5 cm above the elbow in the longitudinal sec-
tion for the scanning of right brachial artery, then the
basal diameter of brachial artery (from anterior intima to
posterior intima) and flow velocity were measured. After-Cardiovascular Ultrasound 2009, 7:25 http://www.cardiovascularultrasound.com/content/7/1/25
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wards, sphygmomamometer cuff was placed on the upper
arm, and inflated at 250 mmHg for 4–5 min, and deflated
abruptly. The flow velocity was recorded within 15 sec-
onds, and postocclusion artery diameters were taken at
60–120 seconds. After a 10 minutes resting interval, 5 mg
sublingual isosorbide dinitrate was administered, and
brachial artery was scanned within the next 5 minutes.
Brachial artery images were taken by two experienced
observers (N.U and S.T) who were blinded to the collat-
eral status of the patients. Diameter measurements were
taken at the end of the diastole (timed by peak of R wave
on electrocardiogram), which were calculated at least
three times, and the average of these measurements were
determined. Endothelium dependent and independent
vasodilations were defined as the percent change in diam-
eter compared with baseline (maximum diameter-base-
line diameter/baseline diameterx100). Two sample cases
of impaired, and preserved endothelium dependent FMD
measurements have been demonstrated in Figures 1 and
2. Intra- and inter-observer variability of FMD measure-
ments were determined from 40 randomly selected bra-
chial artery images (Kappa values were 0.93 for intra- and
0.82 for inter-observer agreements; p < 0.001 for both of
them).
Statistical analysis
Data are expressed as mean ± standard deviation for con-
tinuous variables, and number and percentage of subjects
for categorical ones. Chi-square test with Yates correction
was used to assess the significance of difference between
categorical variables. When the values in the cells were not
enough for chi-square test, Fischer's exact test was used.
Continuous variables were compared by Student t-test or
the Mann-Whitney rank sum test. Multivariable logistic
regression analysis was used to adjust for the characteris-
tics that were significant correlates of collateral develop-
ment in the univariate analysis (with p < 0.1) plus terms
for age and gender due to their well-established associa-
tion with coronary heart disease. Odds ratios (OR) with
two-tailed  p-values and 95% confidence intervals (CI)
were calculated as a measure of the association of the clin-
ical, and therapy-related characteristics with collateral
development. Statistical analyses were performed using
SPSS software package (SPSS Inc., Chicago, Illinois, USA)
version 16.0 for Windows and p < 0.05 was considered
statistically significant.
Results
A total of 257 patients met the angiographic criteria of
having at least one major coronary occlusion, or a stenosis
of  ≥ 95% TIMI ≤ 1 anterograde flow. Eighty-six were
excluded for the following reasons: (1) acute coronary
syndrome within the previous 15 days (n = 53); (2) failing
to give informed consent (n = 15); (3) inadequate angi-
ograms for collateral evaluation (n = 12); (4) presence of
occluded coronary artery that is supplied by the patent
bypass graft (n = 6). Thus, the study group was comprised
of 171 patients. Mean age of the study population was 61
years and 75% were males. Of the 171 patients, 88 (51%)
had well-developed collaterals (30 patients had grade 3
and 58 patients had grade 2 collaterals) whereas 83 (49%)
had impaired collateral development (37 patients had
grade 1 collaterals; 46 patients had grade 0 collaterals).
The prevalence of various demographic, angiographic and
therapy related characteristics of the study subjects at the
time of coronary angiography according to collateral clas-
Two-dimensional images of the brachial artery in a case with preserved endothelium dependent flow mediated dilation Figure 1
Two-dimensional images of the brachial artery in a case with preserved endothelium dependent flow medi-
ated dilation. Brachial artery measurements were made from anterior intima to posterior intima at baseline, and during reac-
tive hyperaemia. Endothelium dependent vasodilation response was 17.1%.Cardiovascular Ultrasound 2009, 7:25 http://www.cardiovascularultrasound.com/content/7/1/25
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sification are shown in Table 1. Subjects with poor collat-
erals were significantly more likely to have diabetes
mellitus (p = 0.001) and less likely to have used statins (p
= 0.083). The prevalence of all other cardiovascular risk
factors and use of medications were similar at different
levels of collaterals.
Mean FMD of the study population was 10.9 ± 5.9%, and
mean nitroglycerin mediated dilation was 13.1 ± 6.2%.
Figure 3 and 4 shows the mean FMD values according to
categories of Rentrop collateral classification. Endothe-
lium dependent vasodilation response was not signifi-
cantly different among good and poor collateral groups
(11.5 ± 5.6% vs. 10.4 ± 6.2%, p = 0.214). Nitroglycerin
mediated dilation was also similar (13.4 ± 5.9% vs. 12.8
± 6.5%, p = 0.521). We have then performed a subgroup
analysis by classifying patients into 4 quartiles according
to FMD results, and found that the presence of good col-
laterals did not differ in the first through fourth quartiles
(p = 0.42). Also, the p value of FMD responses between
quartiles 1 and 4 was still not significant [First quartile:
FMD<6.6%, (n = 42), 43%; fourth quartile: FMD>14.7%,
(n = 41), 57%; p = 0.13].
In multivariable model, diabetic patients were 2.9 times
more likely to have poor collaterals than non-diabetics
(95% CI: 1.6–5.7, p = 0.001), and patients who were not
taking statins were 2 times more likely to have poor collat-
erals than patients taking statins (95% CI: 1.01–3.9, p =
0.048).
Discussion
In this cohort of 171 patients with significant coronary
artery disease we failed to find any association between
FMD of the brachial artery and the extent of angiographi-
cally visible coronary collaterals. To the best of our knowl-
edge this is the first study evaluating the relation between
endothelial function and collateral formation.
Previous studies repeatedly demonstrated that nitric oxide
had a pivotal role in the regulation of collateral artery
development [17-19]. It has been suggested, accordingly,
that endothelial dysfunction of which decreased vasodila-
tor activity of NO is a hallmark, could be one of the poten-
tial mechanisms for the decreased presence of coronary
collaterals.
One possible explanation for our negative finding is that
FMD of the brachial artery examines conduit vessel
response rather than the response of resistance vessels
such as coronary and collateral arteries [12]. In oppose of
this assumption however, many studies have demon-
strated that impaired FMD is significantly associated with
coronary endothelial dysfunction [20-22]. On the other
hand, Anderson et al. recently showed that FMD of the
brachial artery was not very sensitive (49% sensitivity) at
the cut off value > 3% for the detection of coronary
endothelial dysfunction and speculated FMD could not
be used for the prediction of the magnitude of the coro-
nary vasodilator response [23]. Fairly high FMD values
noted in the present trial (10.9 ± 5.9%) may therefore
help to explain why FMD failed to correlate with collateral
score.
Two-dimensional images of the brachial artery in a case with impaired endothelium dependent flow mediated dilation Figure 2
Two-dimensional images of the brachial artery in a case with impaired endothelium dependent flow mediated 
dilation. Brachial artery measurements were made from anterior intima to posterior intima at baseline, and during reactive 
hyperaemia. Endothelium dependent vasodilation response was 4.8%.Cardiovascular Ultrasound 2009, 7:25 http://www.cardiovascularultrasound.com/content/7/1/25
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Another explanation for the lack of association between
FMD and collateral development could be the drug effect.
It has been reported that vasoactive medications have a
significant effect on FMD response of brachial artery to
reactive hyperemia so that it is recommended to stop
these drugs at least four half-lives before FMD measure-
ments [12,13]. Withdrawal of all vasoactive drugs in such
patients with significant coronary disease, however, does
not seem to be ethical. Moreover, many of these drugs
were suggested to be a significant determinant of collat-
eral formation as well [24-26] and study patients were tak-
ing them on the day of collateral evaluation. Thus we did
opt to keep the medication as is. While interpreting our
data however, it should be kept in mind that the responses
of brachial and collateral arteries to vasoactive medica-
tions would not necessarily be the same. Indeed, vasodi-
lator response of collateral arteries to pharmacological
agents have recently been shown to be different from that
of coronary arteries [27,28].
Recent data suggest that vasodilator role of NO in collat-
eral artery development may vary depending on the dura-
tion of coronary occlusion. In an animal model of
collateralogenesis it has been shown that a duration of 9
months is needed for the development of endothelium
dependent relaxation mediated primarily by NO [29].
Since our data did not provide us any information about
the time of coronary stenosis/occlusion, it is possible that
time needed for NO to show its full vasodilatory effect has
not been completed in at least some of our patients. This
may have influenced our results.
It is also possible that the vasodilatory role of NO in col-
lateral arteries might be replaced by other vasoactive influ-
ences like prostaglandins which were shown to have
significant vasodilating effect on collateral vessels [30].
In conclusion, our data suggest that FMD may not be the
mirror of coronary circulation and the lack of a significant
relation between extent of coronary collaterals may be dif-
ferent from its relation of coronary artery disease extent.






Age (years) 61 ± 10 61 ± 11 0.738
Gender, males (%) 65 (78) 64 (73) 0.396
Diabetes mellitus (%) 46 (55) 27 (31) 0.001
Hypertension (%) 49 (59) 56 (64) 0.537
Current smokers (%) 41 (49) 39 (44) 0.506
Daily alcohol consumption (%) 3 (3.4) 3 (3.6) 1.0
BMI, kg/m2 28 ± 4 27 ± 4 0.292
Previous MI (%) 55 (66) 53 (60) 0.413
Previous CABG (%) 14 (17) 12 (14) 0.556
Total cholesterol, mg/dL 180 ± 40 179 ± 44 0.828
LDL-C, mg/dL 109 ± 34 107 ± 40 0.700
HDL-C, mg/dL 41 ± 10 39 ± 9 0.285
Triglycerides, mg/dL 152 ± 91 165 ± 80 0.168
Creatinine, mg/dL 1.1 ± 0.3 1.2 ± 0.9 0.607
LV ejection fraction, % 46 ± 13 49 ± 13 0.182
Number of vessels with significant stenosis (%) 0.995
1 vessel 27 (30.7) 25 (30.1)
2 vessel 26 (29.5) 25 (30.1)
3 vessel 35 (39.8) 33 (39.8)
Lesion location (%) 0.154
Left anterior descending artery 64 (72.7) 66 (79.5)
Circumflex artery 53 (60.2) 53 (63.9)
Right coronary artery 67 (76.1) 55 (66.3)
Cardiovascular medications (%)
Aspirin 72 (87) 74 (84) 0.623
Beta-blockers 57 (69) 56 (64) 0.487
Calcium channel blockers 5 (6) 11 (13) 0.146
ACE-Is or ARBs 57 (69) 62 (71) 0.800
Nitrates 28 (34) 35 (40) 0.413
Statins 50 (60) 64 (73) 0.083
ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CABG, coronary artery bypass grafting; 
HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; LV, left ventricular; MI, myocardial infarctionCardiovascular Ultrasound 2009, 7:25 http://www.cardiovascularultrasound.com/content/7/1/25
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Limitations
The potential limitations of the present study are the rela-
tively small sample size and the cross sectional study
design. Despite this, all demographic and clinical varia-
bles were collected systematically using a prespecified
data collection form and the prospectively collected angi-
ographic, and laboratory data did provide us the opportu-
nity to control for most, if not all of the potential
confounders. Previous data have suggested that FMD is
impaired in patients with coronary artery disease. Mean
FMD values of 10.9 ± 5.9% in this cohort may, thus, be
considered as unexpected. Exclusion of patients with
acute coronary syndrome, high rate of statin use and per-
forming FMD procedure without stopping the vasoactive
medications may account for the fairly high FMD values
observed in this trial. Nevertheless, our finding that FMD
is not related with collateral formation may not be extrap-
olated to coronary artery disease patients with impaired
FMD values. Moreover, manual ultrasonically assessment
of brachial endothelial function is a noisy measurement
with critical technical and interpretative limitations. It
would be interesting to use a commercially available sys-
tem for the automatic assessment of brachial FMD; which
could be a more robust and reproducible tool.
It might be debated that Cohen-Rentrop classification is
semiquantitative and might not represent the collaterals
as precisely as fractional flow reserve (FFR) which is cur-
rently the gold standard for determining the presence and
degree of collaterals. Although hemodynamic assessment
is superior to angiographic assessment in grading collat-
eral circulation, close correlation between Cohen-Rentrop
classification and collateral FFR has been documented
before [31]. Based on these data we preferred to use this
Flow mediated dilation values according to categories of the Rentrop collateral classification Figure 3
Flow mediated dilation values according to categories of the Rentrop collateral classification. Boxes cover the 
95% confidence intervals where the line bisecting the box depicting the mean.Cardiovascular Ultrasound 2009, 7:25 http://www.cardiovascularultrasound.com/content/7/1/25
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widely used, practical angiographic method to grade col-
lateral circulation.
Finally, FMD values may not reflect the true, steady state
FMD values as they may be affected by the coronary angi-
ography. However, although some reports suggested per-
cutaneous coronary intervention procedures had an effect
on FMD measurements, this was not confirmed for diag-
nostic coronary angiography [32].
Conclusion
Our findings indicate that systemic endothelial function
assessed via brachial artery FMD is not associated with the
extent of angiographically visible coronary collateral
development. Further studies are needed to evaluate the
role of endothelial function on collateral formation.
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